(Q34203414)

31 July 2017

title

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer (English)

1 reference

31 July 2017

1 reference

1

Rafael Rosell

1 reference

31 July 2017

2

Giorgio Scagliotti

1 reference

31 July 2017

6

Silvia Novello

1 reference

31 July 2017

Kathleen D Danenberg

3

1 reference

31 July 2017

Reginald V N Lord

4

1 reference

31 July 2017

Gerold Bepler

5

1 reference

31 July 2017

Janine Cooc

7

1 reference

31 July 2017

Lucio Crinò

8

1 reference

31 July 2017

José Javier Sánchez

9

1 reference

31 July 2017

Miquel Taron

10

1 reference

31 July 2017

Corrado Boni

11

1 reference

31 July 2017

Filippo De Marinis

12

1 reference

31 July 2017

Maurizio Tonato

13

1 reference

31 July 2017

Maurizio Marangolo

14

1 reference

31 July 2017

Felice Gozzelino

15

1 reference

31 July 2017

Franceso Di Costanzo

16

1 reference

31 July 2017

Massimo Rinaldi

17

1 reference

31 July 2017

Dennis Salonga

18

1 reference

31 July 2017

Craig Stephens

19

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

22

1 reference

31 July 2017

issue

23

1 reference

31 July 2017

page(s)

3548-3553

1 reference

The effect of stathmin phosphorylation on microtubule assembly depends on tubulin critical concentration

31 July 2017

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Increased expression of mRNAs for microtubule disassembly molecules during nerve regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15.5 and genes in the LOH11A metastasis suppressor region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Mutational analysis of the beta-tubulin gene in lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206419

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206419

1 reference

Dimensions Publication ID

31 July 2017

1041637695

0 references

1 reference